Release details

2017-07-03 13:29 CEST
  • Print
  • Share Share
dk en

Status regarding Novo Nordisk's holding of its own shares (30 June 2017)

Bagsværd, Denmark, 3 July 2017 - In continuation of the company's announcements dated 2 February 2017 and 3 May 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 June 2017 owned 26,782,349 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,356,470 or 1.1% of the total share capital.

In the second quarter of 2017 a total of 13,768,358 B shares were repurchased, and 17,871 B shares were disposed to employees in connection with employee incentive programmes.

Further information

Media:    
Anne Margrethe Hauge +45 4442 3450 amhg@novonordisk.com
Ken Inchausti (US) +1 609 786 8316 kiau@novonordisk.com
     
Investors:    
Peter Hugreffe Ankersen +45 3075 9085 phak@novonordisk.com
Hanna Ögren +45 3079 8519 haoe@novonordisk.com
Anders Mikkelsen +45 3079 4461 armk@novonordisk.com
Kasper Veje (US) +1 609 235 8567 kpvj@novonordisk.com

Company announcement No 53 / 2017 

HUG#2117461